Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial
在完全切除的EGFR突变型IB期非小细胞肺癌患者中，辅助使用埃克替尼与观察的疗效比较（GASTO1003，CORIN）：一项随机、开放标签的II期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.101839
Ou, Wei; Li, Ning; Wang, Bao-Xiao; Zhu, Teng-Fei; Shen, Zhi-Lin; Wang, Tao; Chang, Wu-Guang; Chang, Zeng-Hao; Hu, Xin-Xin; Pu, Yue; Ding, Lie-Ming; Wang, Si-Yu
